Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00797498 · ClinicalTrials.gov registry record

Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses

A clinical trial, sponsored by University of Florida.

Completed
Registry status
174
Enrollment target

NCT00797498: Completed study, sponsored by University of Florida.

NCT00797498 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 174 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00797498 has completed, sponsored by University of Florida.

COMPLETED
Registry status
174 participants
Enrollment target

Study Summary

The purpose of this study is to collect information from a questionnaire and medical records to see what effects proton radiation has on cancer and collect and analyze morbidity outcomes: incidence of Xerostomia (dry mouth) and tumor control.

Interventions

  • OTHER Xerostomia questionnaire

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2006-08
Est. Completion 2015-12
University of Florida

1,106 total trials

What the finished NCT00797498 record still lists

NCT00797498 is an observational study that tracks outcomes without assigning an intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Xerostomia questionnaire is the first listed.

NCT00797498 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00797498 about?

NCT00797498 is a clinical study titled "Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses". The purpose of this study is to collect information from a questionnaire and medical records to see what effects proton radiation has on cancer and collect and analyze morbidity outcomes: incidence of Xerostomia (dry mouth) and tumor control.

What is the current status of trial NCT00797498?

This trial is currently completed. The enrollment target is 174 participants. The study started on 2006-08. Estimated completion is 2015-12.

What interventions are being tested in trial NCT00797498?

The interventions under investigation include: Xerostomia questionnaire (OTHER).

Who is sponsoring clinical trial NCT00797498?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

  • NCT04729114 · 174 participants · Phase 1

    A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • NCT04884035 · 174 participants · Phase 1

    Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

  • NCT05075980 · 174 participants · Phase 2

    Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00797498, the US trial registry maintained by the National Library of Medicine. NCT00797498 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.